Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
40 Cards in this Set
- Front
- Back
cyclophosphamide
|
alkylating agent
DLT: liver problems!! |
|
mephlalan
|
alkylating agent
|
|
chlorambucil
|
alkylating agent
|
|
carmustine
|
alkylating agent
|
|
lomustine
|
alkylating agent
|
|
streptozocin
|
alkylating agent
|
|
thiotepa
|
alkylating agent
|
|
busulfan
|
alkylating agent
|
|
decarbazine
|
alkylating agent
|
|
cisplatin
|
platinum alkylating agent
DLT: nephrotoxicity |
|
carboplatin
|
platinum alkylating agent
|
|
methotrexate
|
antifolate antimetabolite
inhibits DHFR |
|
mercaptopurine
|
antipurine antimetabolite
|
|
thioguanine
|
antipurine antimetabolite
|
|
fludarabine
|
antipurine antimetabolite
|
|
fluorouracil
|
inhibits thymidylate synthetase
resistance: increaesed expr of thymidylate synthetase contradind: DPD deficiency capecitabine is similar but with longer halflife (prodrug) |
|
cytarabine
|
antipyrimidine antimetabolite
|
|
gemcitabine
|
antipyrimidine antimetabolite
|
|
vinblastine
|
vinca alkyloid - spindle poison
MOA: inhibits microtubule polymerization DLT: myelosuppression |
|
vincristine
|
vinca alkyloid - spindle poison
MOA: inhibits microtubule polymerization *** vincristine is marrow sparing! DLT: neurotoxicity |
|
etoposide
|
plant alkyloid
___poside MOA: Topoisomerase II inhibitor, causes DNA strand breaks and cycle arrest DLT: myelosuppresion, N/V, alopecia MOR: for alkyloids, tends to be glycoprotein p efflux pump |
|
irinotecan
|
plant alkyloid
____tecan MOA: topoisomerase I inhibitor DLT: severe GI problems, diarrhea, mucositis myelosuppression? MOR: for alkyloids, tends to be glycoprotein p efflux pump |
|
paclitaxel
|
plant alkyloid
___taxel paclitaxel and docetacel: MOA: MT stabilizer DLT: myelosuppression |
|
docetacel
|
plant alkyloid
____taxel paclitaxel and docetacel: MOA: MT stabilizer DLT: myelosuppression |
|
daunorubicin
|
antitumor antibiotic
daunorubicin is used for acute leukemias DLT: myelosuppression, cardiotoxicity (not as bad as doxorubicin) MOA: VERY PLEOTROPIC!! 1. inhibits topoisomerase II 2. DNA intercalater 3. alteration in membrane fluidity 4. alteration in ion transport 5. generation of free radicals MoR: pglycoprotein efflux, glutathione conj, topo II mut, DNA repair |
|
doxorubicin
|
antitumor antibiotic
doxorubicin is used for solid tumors DLT: CARDIAC TOXICITY! myelosuppression MOA: VERY PLEOTROPIC!! MOA: VERY PLEOTROPIC!! 1. inhibits topoisomerase II 2. DNA intercalater 3. alteration in membrane fluidity 4. alteration in ion transport 5. generation of free radicals MoR: pglycoprotein efflux, glutathione conj, topo II mut, DNA repair |
|
dactinomycin
|
antitumor antibiotic
MOA: intercalates and causes ss strand breaks DLT: myelosuppression, anorexia, N/V, less cardiotoxic than doxorubicin |
|
mitomycin
|
antitumor antibiotic
crosslinks DNA mighty crosslinking |
|
bleomycin
|
antitumor antibiotic
use: squamous cell carcinoma of the cervix, lymphoma, testicular tumors MOA: binds copper and iron and causes DNA breaks following free radical attack DLT: pulmonary toxicity |
|
IFN alpha
|
use: leukemia, sarcoma, squamous cell carcinoma
|
|
IL-2
|
use: renal cell carcinoma, malignant melanoma.
MOA: inc. activity of NK cells |
|
hydroxyurea
|
misc. chemotherapeutic
MOA: inhibit ribonucleotide diphosphate reductase, blocking DNA synthesis NDP's can't be turned into dNDPs.... |
|
prednisone
|
use: leukemia and lymphoma
inhibits T cell proliferation |
|
tamoxifen
|
SERM
|
|
leuprolide
|
inhibits gonadotropin release, suppressing ovarian and testicular steroidogenesis (gonadotropin-releasing hormone analog)
use: hormone stimulated cancer |
|
trastuzumab
|
breast cancer chemotherapeutic
inhibits HER2 overexpressing tumor cell proliferation through antibody-dependent cytotoxicity |
|
imatinib
|
this is Gleevec!! (imagine gleevec)
inhibits TK activity of BCR-ABL use:CML |
|
herceptin
|
antibody
kills tumors expressing her2/neu (breast cancer) |
|
celecoxib
|
apoptosis inducer
|
|
thalidomide
|
anti angiogenic compound
|